Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer
patients are generally low, with few exceptions, regardless of the solid cancer type or drug …

Background: An increasing proportion of patients are exposed to anthracyclines and/or
taxanes in the adjuvant or neoadjuvant setting. Re-exposure in the metastatic stage is …

Pemetrexed-carboplatin and gemcitabine‑vinorelbine combination therapies were
efficacious in phase II and phase III studies as first-line breast cancer treatment. Thus, Arm A …

Background: Many phase II trials investigated the combination of Gemcitabine (G) and
Vinorelbine (V) in the treatment of metastatic breast cancer (MBC) with variable outcomes …

Background: This phase II study was conducted to evaluate the efficacy and safety of the
chemotherapy combination of gemcitabine and vinorelbine in taxane-pretreated Japanese …

Fever is a common feature in various pathological conditions that manifests a series of
molecular events in the internal milieu. Much less attention has been paid to the clinical …

Статья посвящена изучению эффективности и токсичности низких доз
комбинированной химиотерапии гемцитабина с цисплатином для 131 больной …

The complexity of cancer chemotherapy requires pharmacists be familiar with the
complicated regimens and highly toxic agents used. This column reviews various issues …

В общей группе ОО и клинически значимый ответ (КО) оказались достаточно высокими
(26, 7 и 71, 7% соответственно) с медианой ВДП 8, 1 месяца (95% доверительный …

Complete response (CR) rates reported for cytotoxic chemotherapy for late-stage cancer
patients are generally low, with few exceptions, regardless of the solid cancer type or drug …